114 related articles for article (PubMed ID: 14692515)
1. Effects of all-trans retinoic acid (ATRA) on human myeloma cells.
Otsuki T; Sakaguchi H; Hatayama T; Wu P; Takata A; Hyodoh F
Leuk Lymphoma; 2003 Oct; 44(10):1651-6. PubMed ID: 14692515
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibition of a human myeloma cell line by all-trans retinoic acid is not mediated through downregulation of interleukin-6 receptors but through upregulation of p21(WAF1).
Chen YH; Lavelle D; DeSimone J; Uddin S; Platanias LC; Hankewych M
Blood; 1999 Jul; 94(1):251-9. PubMed ID: 10381520
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of myeloma cell growth by all-trans retinoic acid is associated with upregulation of p21WAF1 and dephosphorylation of the retinoblastoma protein.
Lavelle D; Chen YH; Hankewych M; Desimone J
Leuk Lymphoma; 1999 Oct; 35(3-4):261-8. PubMed ID: 10706449
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 10 abolishes the growth inhibitory effects of all-trans retinoic acid on human myeloma cells.
Otsuki T; Yata K; Sakaguchi H; Kurebayashi J; Matsuo Y; Uno M; Fujii T; Eda S; Isozaki Y; Yawata Y; Yamada O; Wada H; Sugihara T; Ueki A
Br J Haematol; 2002 Mar; 116(4):787-95. PubMed ID: 11886382
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone plus retinoids decrease IL-6/IL-6 receptor and induce apoptosis in myeloma cells.
Smith MR; Xie T; Joshi I; Schilder RJ
Br J Haematol; 1998 Sep; 102(4):1090-7. PubMed ID: 9734662
[TBL] [Abstract][Full Text] [Related]
6. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
[TBL] [Abstract][Full Text] [Related]
7. The IL-6 receptor antagonist SANT-7 overcomes bone marrow stromal cell-mediated drug resistance of multiple myeloma cells.
Hönemann D; Chatterjee M; Savino R; Bommert K; Burger R; Gramatzki M; Dörken B; Bargou RC
Int J Cancer; 2001 Sep; 93(5):674-80. PubMed ID: 11477577
[TBL] [Abstract][Full Text] [Related]
8. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E
Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843
[TBL] [Abstract][Full Text] [Related]
9. Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells.
Taetle R; Dos Santos B; Akamatsu K; Koishihara Y; Ohsugi Y
Clin Cancer Res; 1996 Feb; 2(2):253-9. PubMed ID: 9816167
[TBL] [Abstract][Full Text] [Related]
10. [Differentiating effect of PPARgamma ligand rosiglitazone and all trans-retinoic acid on myeloma cells and its possible mechanism].
Huang HW; Chen GH; Chang HR; Chow HC; Leung AY; Liang R; Wu DP
Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):885-9. PubMed ID: 20193324
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of all-trans retinoic acid on the growth of freshly isolated myeloma cells via interference with interleukin-6 signal transduction.
Ogata A; Nishimoto N; Shima Y; Yoshizaki K; Kishimoto T
Blood; 1994 Nov; 84(9):3040-6. PubMed ID: 7949175
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of myeloma cell growth by dexamethasone and all-trans retinoic acid: synergy through modulation of interleukin-6 autocrine loop at multiple sites.
Chen YH; Desai P; Shiao RT; Lavelle D; Haleem A; Chen J
Blood; 1996 Jan; 87(1):314-23. PubMed ID: 8547658
[TBL] [Abstract][Full Text] [Related]
13. All-trans retinoic acid modulates radiation-induced proliferation of lung fibroblasts via IL-6/IL-6R system.
Tabata C; Kubo H; Tabata R; Wada M; Sakuma K; Ichikawa M; Fujita S; Mio T; Mishima M
Am J Physiol Lung Cell Mol Physiol; 2006 Mar; 290(3):L597-606. PubMed ID: 16257998
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid-induced growth inhibition of a human myeloma cell line via down-regulation of IL-6 receptors.
Sidell N; Taga T; Hirano T; Kishimoto T; Saxon A
J Immunol; 1991 Jun; 146(11):3809-14. PubMed ID: 2033252
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid modulates a bimodal effect on cell cycle progression in human adult T-cell leukemia cells.
Dierov J; Sawaya BE; Prosniak M; Gartenhaus RB
Clin Cancer Res; 1999 Sep; 5(9):2540-7. PubMed ID: 10499631
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition of gastric cancer cells by all-trans retinoic acid through arresting cell cycle progression.
Wu Q; Chen Z; Su W
Chin Med J (Engl); 2001 Sep; 114(9):958-61. PubMed ID: 11780391
[TBL] [Abstract][Full Text] [Related]
17. All-trans retinoic acid modulates Fas antigen expression and affects cell proliferation and apoptosis in combination with anti-Fas monoclonal antibody in the human myeloma cell line, U266B1.
Okamura T; Masuda M; Arai Y; Ishida C; Shudou K; Mizoguchi H
Exp Hematol; 1998 Jun; 26(6):501-6. PubMed ID: 9620283
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of caffeic acid phenethyl ester on all-trans retinoic acid-induced differentiation in human leukemia HL-60 cells.
Kuo HC; Kuo WH; Lee YJ; Wang CJ; Tseng TH
Toxicol Appl Pharmacol; 2006 Oct; 216(1):80-8. PubMed ID: 16766008
[TBL] [Abstract][Full Text] [Related]
19. [Synergistic inhibitory effect of all-trans retinoic acid and 1,25-dihydroxy vitamin D3 on growth of human hepatoma cell line HepG2].
Lu HQ; Zheng J
Ai Zheng; 2006 Dec; 25(12):1470-6. PubMed ID: 17166369
[TBL] [Abstract][Full Text] [Related]
20. Treatment of multiple myeloma with all-trans retinoic acid alone and in combination with chemotherapy: a phase I/II trial.
Koskela K; Pelliniemi TT; Pulkki K; Remes K
Leuk Lymphoma; 2004 Apr; 45(4):749-54. PubMed ID: 15160951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
